TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
1.700
+0.070 (4.29%)
Nov 9, 2026, 3:19 PM EST - Market open
TuHURA Biosciences Market Cap
TuHURA Biosciences has a market cap or net worth of $108.34 million as of November 9, 2026. It is the 24,648th most valuable company in the world and the 4,043rd biggest in the United States. Its market cap has decreased by 16.13% in one year.
Market Cap
108.34M
Enterprise Value
116.52M
1-Year Change
-16.13%
Global Rank
Country Rank
#4,043 United States
Category
ChartMarket Cap Chart
Since October 18, 2024, TuHURA Biosciences's market cap has decreased from $264.60M to $108.34M, a decrease of -59.06%. That is a compound annual growth rate of -35.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 108.34M | 135.78% |
| Dec 31, 2025 | 45.95M | -73.43% |
| Dec 31, 2024 | 172.94M | -34.64% |
| Oct 18, 2024 | 264.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 110.38M |
| LENZ Therapeutics | 109.97M |
| Milestone Pharmaceuticals | 107.49M |
| Anavex Life Sciences | 106.60M |
| Outlook Therapeutics | 106.24M |
| Immunic | 105.74M |
| NovaBridge Biosciences | 105.50M |
| NRx Pharmaceuticals | 102.97M |